Systematic Review and Mixed Treatment Comparison of Intravitreal Aflibercept With Other Therapies for Diabetic Macular Edema (DME)

BMC Ophthalmology - United Kingdom
doi 10.1186/s12886-015-0035-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effect of Intravitreal Aflibercept on Recalcitrant Diabetic Macular Edema

International Journal of Retina and Vitreous
Ophthalmology
2017English

Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

Global Journal of Pharmacy & Pharmaceutical Sciences
2018English

Diabetic Macular Edema Treated With Intravitreal Aflibercept Injection After Treatment With Other Anti-Vegf Agents (SWAP-TWO Study): 6-Month Interim Analysis

International Journal of Retina and Vitreous
Ophthalmology
2019English

Comparison of Natural Course, Intravitreal Triamcinolone and Macular Laser Photocoagulation for Treatment of Mild Diabetic Macular Edema

International Journal of Medical Sciences
Medicine
2013English

Pss25 - Cost-Effectiveness Analysis of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema (Dme) Under the Brazilian Public Healthcare System (Sus)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology
Ophthalmology
2012English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Pss5 - Vision-Related Quality of Life in Patients With Diabetic Macular Edema Treated With Intravitreal Aflibercept: The Aqua Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy